|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 |
| (11) | Number of the document | 2588090 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11732405.3 |
| Date of filing the European patent application | 2011-07-01 | |
| (97) | Date of publication of the European application | 2013-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/061140 |
| Date | 2011-07-01 |
| (87) | Number | WO 2012/001156 |
| Date | 2012-01-05 |
| (30) | Number | Date | Country code |
| 201000209 | 2010-07-12 | SI | |
| 201000196 | 2010-07-01 | SI |
| (72) |
KROSELJ, Vesna, SI
JURSA KSELA, Sonja, SI
|
| (73) |
KRKA, tovarna zdravil, d.d., Novo mesto,
Smarjeska cesta 6, 8501 Novo mesto,
SI
|
| (54) | PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |